Latest Articles

Publication Date
Case 330: Ovarian Torsion in the Setting of Ovarian Hyperstimulation Syndrome.

A 30-year-old female patient with a history of infertility and no pregnancy presented to the gynecologic endometriosis clinic for follow-up 1 month after oocyte retrieval, to be evaluated for pelvic …

Published: Oct. 30, 2024, midnight
Synergistic Inhibitory Effects of Tetramethylpyrazine and Evodiamine on Endometriosis Development.

Endometriosis (EMS) belongs to a gynecological disorder with inflammation and the existence of endometrial-like tissues beyond the uterus, often leading to infertility and pelvic pain. Estrogen receptor β (ERβ) is …

Published: Oct. 30, 2024, midnight
Non-Hormonal Therapy for Endometriosis Based on Angiogenesis, Oxidative Stress and Inflammation.

Endometriosis is a common gynecological disease that occurs in between 6 and 10% of women who are at reproductive maturity. The presence of endometrial tissue outside the uterine cavity is …

Published: Oct. 30, 2024, midnight
Combination therapy of Sanjie Zhentong capsules for endometriosis: Impact on hormone regulation and serum expression of FOLR1 and MSLN.

Examining the impact of Sanjie Zhentong capsules on hormone levels and serum expression of folate receptor 1 (FOLR1) and Mesothelin (MSLN) in endometriosis patients. A cohort of 150 endometriosis patients …

Published: Oct. 29, 2024, midnight
Lisata Therapeutics strikes research partnership to investigate new treatment for endometriosis - Proactive financial news

Lisata Therapeutics strikes research partnership to investigate new treatment for endometriosis Proactive financial news

Published: Oct. 28, 2024, 1:52 p.m.
Lisata Therapeutics strikes research partnership to investigate new treatment for endometriosis - Proactive Investors USA

Lisata Therapeutics strikes research partnership to investigate new treatment for endometriosis Proactive Investors USA

Published: Oct. 28, 2024, 1:52 p.m.
Lisata Therapeutics strikes research partnership to investigate new treatment for endometriosis - Proactive Investors Australia

Lisata Therapeutics strikes research partnership to investigate new treatment for endometriosis Proactive Investors Australia

Published: Oct. 28, 2024, 1:52 p.m.
Lisata Therapeutics Announces Sponsored Preclinical Research Agreement with the University of Cincinnati to Study Certepetide for the Treatment of Endometriosis - StockTitan

Lisata Therapeutics Announces Sponsored Preclinical Research Agreement with the University of Cincinnati to Study Certepetide for the Treatment of Endometriosis StockTitan

Published: Oct. 28, 2024, 12:30 p.m.
Dissecting the cell microenvironment of ovarian endometrioma through single-cell RNA sequencing.

Ovarian endometrioma (OE), also known as "chocolate cysts," is a cystic mass that develops in the ovaries due to endometriosis and is a common gynecological condition characterized by the growth …

Published: Oct. 28, 2024, midnight
Patient-centered endometriosis care implementation at tertiary and secondary care hospitals in Indonesia.

Endometriosis has a high recurrence rate within five years (40-50 %). High recurrence remarkably reduces Health-Related Quality of Life (HRQOL). Patient-centered endometriosis care (PCEC) is a range of care that …

Published: Oct. 28, 2024, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!